Search peptides, terms, sources/
Research source · 2020

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

About this source

Kind
Research
Design
In-vitro
Population
Cell-based receptor assays, primary islets
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

In-vitro only, mechanism-level evidence.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.